Primary Peritoneal Carcinoma Active Not Recruiting Phase 2 Trials for Avelumab (DB11945)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03312114Anti—PD-L1 and SAbR for Ovarian CancerTreatment